
Wastewater Pathogen Variant Analytics Market Report 2026
Global Outlook – By Pathogen Type (Viruses, Bacteria, Parasites, Fungi), By Technology (Polymerase Chain Reaction (PCR)-Based, Next-Generation Sequencing, Immunoassays, Biosensors, Other Technologies), By Application (Public Health Surveillance, Environmental Monitoring, Industrial Wastewater, Municipal Wastewater, Other Applications), By End-User (Municipalities, Research Institutes, Industrial Facilities, Healthcare Facilities, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Wastewater Pathogen Variant Analytics Market Overview
• Wastewater Pathogen Variant Analytics market size has reached to $1.62 billion in 2025 • Expected to grow to $3.63 billion in 2030 at a compound annual growth rate (CAGR) of 17.6% • Growth Driver: Rising Prevalence Of Infectious Diseases Fueling The Growth Of The Wastewater Pathogen Variant Analytics Market Due To Increasing Global Travel And Mobility • Market Trend: Advancements In Next-Generation Sequencing And Molecular Technologies For Enhanced Wastewater Pathogen Surveillance • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Wastewater Pathogen Variant Analytics Market?
Wastewater pathogen variant analytics refers to the analysis of genetic material from pathogens found in wastewater to identify, track, and monitor different variants or strains circulating in a community. By sequencing and analyzing pathogen genomes shed in human waste, this approach provides early warning of outbreaks, tracks the emergence and spread of new variants, and supports public health surveillance without relying solely on clinical testing. The main pathogen types of wastewater pathogen variant analytics include viruses, bacteria, parasites, and fungi. Viruses are monitored to detect, track, and analyze pathogen variants in wastewater, helping inform public health responses and environmental safety measures. They utilize technologies such as polymerase chain reaction (PCR)-based methods, next-generation sequencing, immunoassays, biosensors, and other technologies. The various applications involved are public health surveillance, environmental monitoring, industrial wastewater, municipal wastewater, and other applications, and they are utilized by end users including municipalities, research institutes, industrial facilities, healthcare facilities, and other end-users.
What Is The Wastewater Pathogen Variant Analytics Market Size and Share 2026?
The wastewater pathogen variant analytics market size has grown rapidly in recent years. It will grow from $1.62 billion in 2025 to $1.9 billion in 2026 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to growing awareness of community-level disease monitoring, adoption of pcr-based pathogen detection, rising municipal wastewater testing, development of environmental monitoring labs, increased funding for public health surveillance.What Is The Wastewater Pathogen Variant Analytics Market Growth Forecast?
The wastewater pathogen variant analytics market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2030 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to expansion of next-generation sequencing technologies, integration with ai and big data analytics, increased government initiatives for outbreak prediction, demand for real-time wastewater monitoring, collaboration between municipalities and research institutes. Major trends in the forecast period include wastewater genomic surveillance, real-time pathogen variant tracking, ai-powered outbreak prediction, integration with public health dashboards, predictive environmental risk analytics.Global Wastewater Pathogen Variant Analytics Market Segmentation
1) By Pathogen Type: Viruses, Bacteria, Parasites, Fungi 2) By Technology: Polymerase Chain Reaction (PCR)-Based, Next-Generation Sequencing, Immunoassays, Biosensors, Other Technologies 3) By Application: Public Health Surveillance, Environmental Monitoring, Industrial Wastewater, Municipal Wastewater, Other Applications 4) By End-User: Municipalities, Research Institutes, Industrial Facilities, Healthcare Facilities, Other End-Users Subsegments: 1) By Viruses: Ribonucleic Acid (RNA) Viruses, Deoxyribonucleic Acid (DNA) Viruses 2) By Bacteria: Pathogenic Bacterial Species, Antimicrobial-Resistant Strains 3) By Parasites: Protozoa, Helminth-Related Pathogens 4) By Fungi: Fungal Pathogens, Environmental Fungal VariantsWhat Is The Driver Of The Wastewater Pathogen Variant Analytics Market?
The rising prevalence of infectious diseases is expected to propel the growth of the wastewater pathogen variant analytics market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly among populations. The growing burden of infectious diseases is driven by factors such as increased global travel and mobility, urbanization, and heightened risk of cross-border transmission, which accelerate the spread of emerging and re-emerging pathogens. Wastewater pathogen variant analytics address this rising burden by enabling early detection of pathogens and their variants at the community level, allowing faster public health responses and more targeted interventions to limit transmission. For instance, in February 2026, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, seasonal influenza in the United States resulted in approximately 290,000–450,000 hospitalizations and 34,000–53,000 deaths annually, while respiratory syncytial virus (RSV) accounted for an estimated 190,000–350,000 hospitalizations and 10,000–23,000 deaths. Therefore, the rising prevalence of infectious diseases is expected to drive the growth of the wastewater pathogen variant analytics industry.Key Players In The Global Wastewater Pathogen Variant Analytics Market
Major companies operating in the wastewater pathogen variant analytics market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., SGS SA, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., BioMérieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories, QIAGEN N.V., ALS Limited, Promega Corporation, Ginkgo Bioworks Inc., Oxford Nanopore Technologies plc, LuminUltra Technologies Ltd., Verily Life Sciences LLC, Zymo Research Corp., PathogenDx Inc., Clear Labs Inc., GT Molecular Inc.Global Wastewater Pathogen Variant Analytics Market Trends and Insights
Major companies operating in the wastewater pathogen variant analytics market are increasingly focusing on technological advancements in advanced molecular diagnostics platforms to enhance detection accuracy, improve real-time pathogen surveillance, and support early identification of emerging public health threats. Molecular diagnostic technologies use nucleic-acid–based methods, such as PCR and sequencing, to detect and quantify DNA or RNA from pathogens in complex samples, including wastewater. For instance, in April 2025, bioMérieux, a France-based company involved in in-vitro diagnostics, launched WATCHFIRE, an innovative molecular testing solution designed to strengthen wastewater pathogen surveillance through rapid, multiplex PCR detection of up to 22 respiratory pathogens directly from sewage influent samples. The system delivers results in approximately 45 minutes and integrates with FIREWORKS software to enable real-time trend analysis and automated alerts, supporting early warning and outbreak monitoring. WATCHFIRE runs on the BIOFIRE FILMARRAY TORCH instrument, enabling decentralized, near-source testing with minimal hands-on time, and is expected to expand later in the year to include a gastrointestinal panel, broadening pathogen coverage and complementing sequencing-based variant analytics for public health authorities.What Are Latest Mergers And Acquisitions In The Wastewater Pathogen Variant Analytics Market?
In October 2023, Verily Life Sciences LLC, a US-based precision health technology company offering wastewater surveillance services, laboratory analysis, and data science solutions, partnered with the U.S. Centers for Disease Control and Prevention (CDC) to support the National Wastewater Surveillance System (NWSS) by providing nationwide wastewater testing services for pathogen detection including SARS-CoV-2 and MPXV. Through this collaboration, Verily aims to enhance its public health surveillance capabilities and expand its footprint in real-time wastewater epidemiology to generate actionable data that informs outbreak detection and disease trend analysis. The U.S. Centers for Disease Control and Prevention (CDC) is a US–based national public health institute tasked with disease control, prevention programs, public health guidance, and surveillance systems to protect public health and safety.Regional Insights
North America was the largest region in the wastewater pathogen variant analytics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Wastewater Pathogen Variant Analytics Market?
The wastewater pathogen variant analytics market includes revenues earned by providing services such as epidemiological modeling and outbreak forecasting services, customized assay development services, regulatory compliance and validation services, predictive hotspot identification services, emergency outbreak surge testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The wastewater pathogen variant market consists of sales of portable field-deployable molecular testing devices, smart sewer network monitoring sensors, mutation frequency quantification modules, automated liquid handling robotic systems, metagenomic library preparation automation kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data And Analysis Are Included In The Wastewater Pathogen Variant Analytics Market Report 2026?
The wastewater pathogen variant analytics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the wastewater pathogen variant analytics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Wastewater Pathogen Variant Analytics Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.9 billion |
| Revenue Forecast In 2035 | $3.63 billion |
| Growth Rate | CAGR of 17.4% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Pathogen Type, Technology, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., SGS SA, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., BioMérieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories, QIAGEN N.V., ALS Limited, Promega Corporation, Ginkgo Bioworks Inc., Oxford Nanopore Technologies plc, LuminUltra Technologies Ltd., Verily Life Sciences LLC, Zymo Research Corp., PathogenDx Inc., Clear Labs Inc., GT Molecular Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
